Physician profile
Neda Nikpoor
NPI 1598024077
$292,680.65
in general payments reported to CMS, 2019-2025
34 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $6,960 · 2021: $23K · 2022: $67K · 2023: $55K · 2024: $51K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $101K · Food and Beverage: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Travel and Lodging: $2,864 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $101,108.98 |
| Food and Beverage | $27,842.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,790.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,065.00 |
| Travel and Lodging | $2,864.21 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $76,838.20 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Abbvie INC. | $35,313.60 | 2022-2025 | |
| Lensar, INC. | $30,267.84 | 2021-2025 | Lensar Laser System |
| Sun Pharmaceutical Industries INC. | $23,883.43 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Alcon Vision LLC | $23,500.20 | 2019-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Johnson & Johnson Surgical Vision, INC. | $21,092.45 | 2019-2025 | Tecnis Iol, Compact Intuitiv, Healon Duet Pro |
| Allergan, INC. | $19,351.22 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $18,790.49 | 2022-2025 | Miebo, Xiidra, Teneo |
| Ziemer USA | $12,878.18 | 2019-2020 | |
| Dompe US, INC. | $6,713.99 | 2021-2025 | Oxervate |
| Glaukos Corporation | $4,520.50 | 2021-2025 | Ce-Marked Kxla System, Idosetr, Photrexa Viscous and Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,487.35 | 2019-2021 | |
| Sight Sciences, INC. | $3,486.83 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $2,793.20 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $2,646.42 | 2022-2025 | Tyrvaya, Ryzumvi |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $1,566.71 | 2021-2022 | |
| Beaver-Visitec International, INC. | $1,057.67 | 2019-2025 | |
| Alcon Research LLC | $808.36 | 2022-2023 | Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $759.93 | 2019-2023 | |
| Biotissue Holdings INC. | $682.53 | 2020-2025 | |
| Ivantis, INC | $229.23 | 2021 | |
| Horizon Therapeutics Plc | $198.20 | 2022-2023 | Tepezza |
| Amgen INC. | $188.00 | 2024 | Tepezza |
| Aerie Pharmaceuticals, INC. | $156.61 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $80.11 | 2023 | Callisto Eye |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Lumibird Medical INC. | $58.28 | 2025 | |
| Harrow Eye, LLC | $55.97 | 2023-2025 | Iheezo, Flarex, Verkazia |
| Staar Surgical Company | $55.80 | 2019 | |
| Shire North American Group INC | $39.63 | 2019 | |
| Eyevance Pharmaceuticals LLC | $35.48 | 2020-2021 | |
| Eyepoint US, INC. | $32.94 | 2021 | |
| Mallinckrodt Hospital Products INC. | $27.18 | 2022 | |
| Welch Allyn | $19.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Nikpoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.